AS, Remicade and New Brunswick

In a similar vein, the Fredericton Daily Gleaner reports that a New Brunswick man with ankylosing spondylitis is lobbying the provincial government to approve coverage for Remicade (infliximab) for the treatment of AS. It appears that the provincial drug plan is lagging behind both Blue Cross and Health Canada, both of which have approved Remicade for AS.